Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03996889
Other study ID # VAP-AURC
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 2019
Est. completion date September 2022

Study information

Verified date July 2019
Source Hospices Civils de Lyon
Contact Nellie DELLA SCHIAVA, MD
Phone 4 72 11 76 76
Email dellaschiava.nellie@neuf.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This multicentric, prospective study will evaluate the medium-term outcomes of patients implanted with GORE VIABAHN® stent grafts for popliteal artery aneurysms in scheduled elective surgery with the registry of the Research in Vascular Surgery University Association (AURC)


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date September 2022
Est. primary completion date September 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- > 18 years old at time of treatment

- symptomatic or asymptomatic popliteal artery aneurysm needing surgery

- scheduled elective surgery

Exclusion Criteria:

- life expectancy of <1 year

- thrombotic occlusion of popliteal artery

- intolerance to antiplatelet drugs (antiaggregants)

- known allergies to GORE VIABAHNĀ® stent graft materials/composition

- emergency surgery

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Endovascular treatment of aneurysms of the popliteal artery by GORE VIABAHN® stent in elective surgery
The intervention can be performed under local anesthesia (LA), regional locus (ALR) or general anesthesia (AG) (data collected) by first approach: percutaneous or conventional. The data collected are: Number of GORE VIABAHN® stent used (length and diameter of each) Embolization of collaterals and other related actions Operative complications Intraoperative fibrinolysis Collar cover> 2 cm Lack of overlap in the "overlap zone" (nb: between 4 and 8 cm above the joint spacing) Arteriography in profile, kink

Locations

Country Name City State
France Hôpital pneumologique et cardiovasculaire Louis Pradel (HCL) Bron

Sponsors (1)

Lead Sponsor Collaborator
Hospices Civils de Lyon

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Major limb events Composite criterion associating Target Lesion Revascularization (TLR) and Rate of major amputation.
An Echo-Doppler imaging examination will be performed and the following parameters and information should be collected:
Permeability
Intra-stent restenosis
Systolic pressure index
2 years of follow-up
See also
  Status Clinical Trial Phase
Recruiting NCT04907240 - Observational GORE® VIABAHN® Endoprosthesis With PROPATEN Bioactive Surface Global Registry